Letybo

Letybo is South Korea's leading aesthetic neuromodulator, made by Hugel and FDA-approved in early 2024 as a sister product to Botox / Dysport / Jeuveau. It softens dynamic facial lines — glabellar (“the 11s”), forehead, and crow's feet — with the same active class (botulinum toxin type A) as Botox, in the clean clinical aesthetic preferred by Korean skincare brands. Treatment is fast (~15 min injection + brief consult). Onset 3-5 days, peak at ~2 weeks, lasts 3-4 months on average. Pricing is $695 flat per vial / treatment. All Letybo treatments are performed by — or under the supervision of — our Medical Director, Kyra Slade NP (pronounced “KAI-RAH”), of VITALHEALTHNP PLLC.